Tag - astrazeneca

 
 

ASTRAZENECA

Hiroyuki Okuzawa, chief operating officer of Daiichi Sankyo, during an interview in Tokyo on Friday
BUSINESS / Companies
Oct 11, 2024
Daiichi Sankyo eyes newer cancer drugs to stave off rivals
The Japanese drugmaker has emerged as a leader in ADC, a type of cancer therapy that targets cancerous cells while sparing the healthy ones.
People walk past the AstraZeneca booth during the first China International Supply Chain Expo (CISCE) in Beijing on Nov. 28, 2023.
BUSINESS / Companies
Sep 16, 2024
AstraZeneca’s blockbuster drug scores major win in combatting bladder cancer
In patients with muscle-invasive bladder cancer, the drug Imfinzi reduced the risk of disease recurring by 32% when given alongside the current standard of care.
Japan Times
BUSINESS / Companies
Jun 7, 2023
AstraZeneca’s Japan partner to go solo on future cancer drugs
Daiichi Sankyo is expanding its sales and development staff overseas, aiming to boost production capacity so that it can handle its cancer drugs business entirely on its own.
Japan Times
WORLD / Science & Health
Oct 18, 2022
High hopes for nasal COVID-19 vaccines despite 'disappointing' trial
By entering the body the same way as the virus, nasal vaccines aim to build immunity in the mucous membrane that line the nose and mouth.
Japan Times
JAPAN / Science & Health
Aug 30, 2022
Japan OKs third Pfizer shot for children and AstraZeneca COVID treatment
Children between the ages of 5 and 11 will be able to get the booster shot five months or more after they received their second dose.
Japan Times
COMMENTARY / World
Jun 8, 2022
The drug that could transform breast cancer treatment
The early success of Enhertu, from AstraZeneca and Daiichi Sankyo, bodes well for an entire class of medicines that may one day replace conventional chemotherapy.
Japan Times
JAPAN / Science & Health
Apr 11, 2022
Japan cancels purchase of 40 million Astrazeneca vaccine doses
The government had originally agreed to buy 120 million of the shots, with the bulk made domestically by Daiichi Sankyo Co. and other local partners.
Japan Times
JAPAN
Feb 7, 2022
Japan's booster rollout is relying on Pfizer and Moderna. How do the shots compare?
Despite an apparent preference among some in the general public for Pfizer, experts have emphasized that getting a booster jab as soon as one is eligible, no matter which type, is key.
Japan Times
JAPAN / Explainer
Jan 6, 2022
The ins and outs of Japan's COVID-19 booster shot rollout
Japan recommends people receive a different shot for their third doses to the one they received in the initial rollout, but what's the rationale behind that strategy?
Japan Times
COMMENTARY / World
Nov 26, 2021
Did AstraZeneca keep Britain safer from COVID-19 than Europe?
It's suggested that Britain's home-grown jab may be the reason the country is faring better with the latest COVID-19 wave than Europe. Still, is there evidence for that?
Japan Times
JAPAN
Sep 14, 2021
Japan to donate 1.3 million more AstraZeneca vaccine doses to Taiwan and Asian neighbors
Taiwan will get 500,000 more doses, bringing Japan's total donation to the island to 3.9 million, Foreign Minister Toshimitsu Motegi told reporters.
Japan Times
LIFE / Lifestyle
Aug 22, 2021
Here’s how to treat COVID-19 vaccine side effects
There's no guarantee that you'll experience side effects from your COVID-19 vaccination, but it doesn't hurt to be prepared for them anyway.
Japan Times
JAPAN
Jul 30, 2021
Health ministry panel approves AstraZeneca’s vaccine for people 40 and over
The panel also backed a proposal to make the shot available to people under age 40 who wish to get AstraZeneca's jab or who are allergic to the ingredients of the mRNA vaccines.
Japan Times
WORLD
Jul 22, 2021
Two doses of Pfizer or AstraZeneca shots effective against delta variant, study finds
The study reiterated that one shot of the vaccines is not enough for high protection from the highly transmissible variant.
Japan Times
ASIA PACIFIC
Jul 10, 2021
North Korea rejected AstraZeneca's COVID-19 vaccine over side effects, think tank claims
North Korea has rejected planned shipments of AstraZeneca's COVID-19 vaccine that were being organized under the global COVAX distribution plan due to concerns over side effects, a South Korean think tank said Friday.
Japan Times
ASIA PACIFIC
Jun 30, 2021
Australia hit by new lockdown as slow vaccine rollout criticized
Since the weekend, more than 12 million Australians have been ordered to stay home in cities across the country, including the state capitals of Sydney, Brisbane and Perth.
Japan Times
WORLD
Jun 20, 2021
Many Brazilians insist on Pfizer even as nation passes 500,000 COVID-19 deaths
In Sao Paulo, people demand the U.S. company's shots at public clinics and often walk out if none are available.
Japan Times
JAPAN
May 28, 2021
Japan to consider sharing COVID-19 vaccines amid calls to help Taiwan
Japan approved AstraZeneca's vaccine last week, but there are no immediate plans to use the shots in the country amid lingering concerns over rare blood clots.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?